164.76
price down icon1.88%   -3.4259
 
loading
Schlusskurs vom Vortag:
$168.19
Offen:
$167.5
24-Stunden-Volumen:
160.96K
Relative Volume:
0.13
Marktkapitalisierung:
$20.65B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-93.62
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
-4.83%
1M Leistung:
-1.45%
6M Leistung:
+35.37%
1J Leistung:
+136.56%
1-Tages-Spanne:
Value
$164.33
$168.88
1-Wochen-Bereich:
Value
$164.51
$180.41
52-Wochen-Spanne:
Value
$69.74
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
3,293
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
164.68 20.65B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
536.57 205.72B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
211.64 149.54B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
135.86 39.02B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
458.19 37.08B 3.90B 887.87M 808.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
193.96 34.17B 15.41B 1.37B 2.11B 7.50

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
03:37 AM

Rhumbline Advisers Sells 1,620 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

03:37 AM
pulisher
03:31 AM

Vontobel Holding Ltd. Lowers Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

03:31 AM
pulisher
Feb 20, 2025

Natera, Inc. (NASDAQ:NTRA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Natera (NTRA) to Release Earnings on Wednesday - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Alberta Investment Management Corp Sells 5,011,459 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Natera, Inc. (NASDAQ:NTRA) Shares Bought by Van ECK Associates Corp - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Natera (NTRA) Surged on Blowout Quarterly Results - Insider Monkey

Feb 19, 2025
pulisher
Feb 19, 2025

Natera, Inc. (NASDAQ:NTRA) Shares Sold by Principal Financial Group Inc. - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Chevy Chase Trust Holdings LLC Boosts Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

Banque Pictet & Cie SA Decreases Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025 - Business Wire

Feb 18, 2025
pulisher
Feb 18, 2025

Natera, Inc. (NASDAQ:NTRA) Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Natera (NTRA) Recently Broke Out Above the 20-Day Moving Average - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Quent Capital LLC Sells 3,008 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

Feb 17, 2025
pulisher
Feb 17, 2025

Natera CEO Steven Chapman sells $12.96m in stock - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

Natera CFO Michael Burkes sells $4.28m in stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Natera's chief legal officer sells $3.64 million in stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

11,294 Shares in Natera, Inc. (NASDAQ:NTRA) Bought by Guided Capital Wealth Management LLC - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

Allspring Global Investments Holdings LLC Sells 115,810 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Natera, Inc. (NASDAQ:NTRA) Stock Holdings Lowered by abrdn plc - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Empowered Funds LLC Decreases Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Natera stock holds at $175 target, Raymond James sees progress - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Sumitomo Mitsui Trust Group Inc. Purchases 69,455 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Canaccord maintains $180 target on Natera stock post-NCCN update - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Mirae Asset Global Investments Co. Ltd. Sells 42,869 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Lecap Asset Management Ltd. Sells 3,150 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

John Fesko Sells 663 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat

Feb 12, 2025
pulisher
Feb 10, 2025

Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj - CNBC

Feb 10, 2025
pulisher
Feb 10, 2025

October 17th Options Now Available For Natera (NTRA) - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

Natera, Inc. Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Yahoo Finance

Feb 10, 2025
pulisher
Feb 09, 2025

Chicago Partners Investment Group LLC Invests $297,000 in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Feb 09, 2025
pulisher
Feb 09, 2025

Natera president sells $290,120 in common stock - MSN

Feb 09, 2025
pulisher
Feb 09, 2025

Natera, Inc. (NASDAQ:NTRA) CFO Sells $7,694,633.76 in Stock - MarketBeat

Feb 09, 2025
pulisher
Feb 09, 2025

Natera, Inc. (NASDAQ:NTRA) Shares Sold by Calamos Advisors LLC - MarketBeat

Feb 09, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$248.84
price down icon 0.21%
diagnostics_research DGX
$172.00
price down icon 0.10%
diagnostics_research WAT
$379.65
price down icon 0.42%
diagnostics_research MTD
$1,295.57
price down icon 1.00%
diagnostics_research IQV
$194.30
price up icon 0.19%
Kapitalisierung:     |  Volumen (24h):